Literature DB >> 17078008

High rate of percutaneous endoscopic gastrostomy site infections due to oropharyngeal colonization.

Sandra Faias1, Marília Cravo, Isabel Claro, Pedro Lage, Carlos Nobre-Leitão.   

Abstract

We prospectively analyzed peristomal infection agents during the first week following percutaneous endoscopic gastrostomy (PEG) placement by the pull technique in patients with head and neck cancer. Nasal and pharyngeal swabs were obtained from a consecutive series of cancer patients prior to PEG placement. All patients underwent antibiotic prophylaxis with cefotaxime and oral disinfection. PEG site infection was prospectively evaluated at days 2, 3, and 7 after insertion. Twenty-eight patients (25 males; mean age, 58 years) were included. Oropharyngeal or nasal colonization were observed in 68% (19/28) and 19% (5/28) of patients, respectively. Early infections occurred in 36% (10/28) of the patients, all with oropharyngeal colonization and concordance between agents (P=0.01). Three patients required hospital admission and 1 required surgery. Head and neck cancer patients with oropharyngeal colonization have a high risk of early PEG site infection with substantial morbidity owing to oral-stomal spread.

Entities:  

Mesh:

Year:  2006        PMID: 17078008     DOI: 10.1007/s10620-006-9216-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  18 in total

1.  Meta-analysis of randomized, controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy.

Authors:  V K Sharma; C W Howden
Journal:  Am J Gastroenterol       Date:  2000-11       Impact factor: 10.864

2.  Methicillin-resistant Staphylococcus aureus infection of percutaneous endoscopic gastrostomy sites.

Authors:  M Hull; A Beane; J Bowen; C Settle
Journal:  Aliment Pharmacol Ther       Date:  2001-12       Impact factor: 8.171

Review 3.  Infection control during gastrointestinal endoscopy: guidelines for clinical application. From the ASGE. American Society for Gastrointestinal Endoscopy.

Authors: 
Journal:  Gastrointest Endosc       Date:  1999-06       Impact factor: 9.427

4.  PEG site infections: the emergence of methicillin resistant Staphylococcus aureus as a major pathogen.

Authors:  Kamran A Chaudhary; Owen J Smith; Paul G Cuddy; Wendell K Clarkston
Journal:  Am J Gastroenterol       Date:  2002-07       Impact factor: 10.864

Review 5.  Complications of enteral access.

Authors:  Stephen A McClave; Wei-Kuo Chang
Journal:  Gastrointest Endosc       Date:  2003-11       Impact factor: 9.427

6.  Antibiotic prophylaxis in percutaneous endoscopic gastrostomy.

Authors:  T M Sturgis; W Yancy; J C Cole; D D Proctor; B S Minhas; S P Marcuard
Journal:  Am J Gastroenterol       Date:  1996-11       Impact factor: 10.864

Review 7.  Gastrostomy tube infections in a community hospital.

Authors:  E C Pien; K E Hume; F D Pien
Journal:  Am J Infect Control       Date:  1996-10       Impact factor: 2.918

8.  Percutaneous endoscopic gastrostomy by the "pull" and "introducer" methods.

Authors:  M Deitel; M Bendago; E H Spratt; C J Burul; T B To
Journal:  Can J Surg       Date:  1988-03       Impact factor: 2.089

9.  Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. A prospective, randomized, double-blind clinical trial.

Authors:  N K Jain; D E Larson; K W Schroeder; D D Burton; K P Cannon; R L Thompson; E P DiMagno
Journal:  Ann Intern Med       Date:  1987-12       Impact factor: 25.391

10.  Guidelines of the European Society of Gastrointestinal Endoscopy (E.S.G.E.) antibiotic prophylaxis for gastrointestinal endoscopy. European Society of Gastrointestinal Endoscopy.

Authors:  J R Rey; A Axon; A Budzynska; A Kruse; A Nowak
Journal:  Endoscopy       Date:  1998-03       Impact factor: 10.093

View more
  7 in total

1.  Percutaneous Endoscopic Gastrostomy: Technical Problems, Complications, and Management.

Authors:  Savas Yuruker; Bulent Koca; Ilhan Karabicak; Bekir Kuru; Necati Ozen
Journal:  Indian J Surg       Date:  2015-01-23       Impact factor: 0.656

2.  Successful control of peristomal infection by introducer-type percutaneous endoscopic gastrostomy: a retrospective historical control study.

Authors:  Chul-Hyun Lim; Jae Myung Park; Yu Kyung Cho; In Seok Lee; Sang Woo Kim; Myung-Gyu Choi; In-Sik Chung
Journal:  Dig Dis Sci       Date:  2011-01-23       Impact factor: 3.199

3.  Comparison of clinical outcomes associated with pull-type and introducer-type percutaneous endoscopic gastrostomies.

Authors:  Sin Won Lee; Jeong Hoon Lee; Hyungjin Cho; Yeonjung Ha; Hyun Lim; Ji Yong Ahn; Kwi Sook Choi; Do Hoon Kim; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung; Jin-Ho Kim
Journal:  Clin Endosc       Date:  2014-11-30

4.  Risk factors and complications following percutaneous endoscopic gastrostomy: a case series of 1041 patients.

Authors:  Hans Juergen Richter-Schrag; Sabine Richter; Olaf Ruthmann; Manfred Olschewski; Ulrich Theodor Hopt; Andreas Fischer
Journal:  Can J Gastroenterol       Date:  2011-04       Impact factor: 3.522

5.  [Percutaneous endoscopic gastrostomy. Complications with and without anticoagulation].

Authors:  O Ruthmann; A Seitz; S Richter; G Marjanovic; M Olschewski; U T Hopt; A Fischer; H-J Schrag
Journal:  Chirurg       Date:  2010-03       Impact factor: 0.955

6.  Airway infection predisposes to peristomal infection after percutaneous endoscopic gastrostomy with high concordance between sputum and wound isolates.

Authors:  Chiao-Hsiung Chuang; Kuei-Hsiang Hung; Jen-Ru Chen; Chiung-Yu Chen; Ai-Wen Kao; Wei-Lun Chang; Jiunn-Jong Wu; Bor-Shyang Sheu
Journal:  J Gastrointest Surg       Date:  2009-10-09       Impact factor: 3.452

7.  Different clinical utility of oropharyngeal bacterial screening prior to percutaneous endoscopic gastrostomy in oncological and neurological patients.

Authors:  Radek Kroupa; Jana Jurankova; Milan Dastych; Michal Senkyrik; Tomas Pavlik; Jitka Prokesova; Marketa Jecmenova; Jiri Dolina; Ales Hep
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.